Unknown

Dataset Information

0

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.


ABSTRACT: Malignant cells often display defects in autophagy, an evolutionarily conserved pathway for degrading long-lived proteins and cytoplasmic organelles. However, as yet, there is no genetic evidence for a role of autophagy genes in tumor suppression. The beclin 1 autophagy gene is monoallelically deleted in 40-75% of cases of human sporadic breast, ovarian, and prostate cancer. Therefore, we used a targeted mutant mouse model to test the hypothesis that monoallelic deletion of beclin 1 promotes tumorigenesis. Here we show that heterozygous disruption of beclin 1 increases the frequency of spontaneous malignancies and accelerates the development of hepatitis B virus-induced premalignant lesions. Molecular analyses of tumors in beclin 1 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Furthermore, beclin 1 heterozygous disruption results in increased cellular proliferation and reduced autophagy in vivo. These findings demonstrate that beclin 1 is a haplo-insufficient tumor-suppressor gene and provide genetic evidence that autophagy is a novel mechanism of cell-growth control and tumor suppression. Thus, mutation of beclin 1 or other autophagy genes may contribute to the pathogenesis of human cancers.

SUBMITTER: Qu X 

PROVIDER: S-EPMC297002 | biostudies-literature | 2003 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Qu Xueping X   Yu Jie J   Bhagat Govind G   Furuya Norihiko N   Hibshoosh Hanina H   Troxel Andrea A   Rosen Jeffrey J   Eskelinen Eeva-Liisa EL   Mizushima Noboru N   Ohsumi Yoshinori Y   Cattoretti Giorgio G   Levine Beth B  

The Journal of clinical investigation 20031124 12


Malignant cells often display defects in autophagy, an evolutionarily conserved pathway for degrading long-lived proteins and cytoplasmic organelles. However, as yet, there is no genetic evidence for a role of autophagy genes in tumor suppression. The beclin 1 autophagy gene is monoallelically deleted in 40-75% of cases of human sporadic breast, ovarian, and prostate cancer. Therefore, we used a targeted mutant mouse model to test the hypothesis that monoallelic deletion of beclin 1 promotes tum  ...[more]

Similar Datasets

| S-EPMC3507442 | biostudies-literature
| S-EPMC7310550 | biostudies-literature
| S-EPMC2254521 | biostudies-literature
| S-EPMC5992097 | biostudies-literature
| S-EPMC5420314 | biostudies-literature
| S-EPMC3542764 | biostudies-other
| S-EPMC6274625 | biostudies-literature
| S-EPMC3801434 | biostudies-literature
| S-EPMC3419265 | biostudies-literature
2011-01-28 | E-GEOD-26850 | biostudies-arrayexpress